688266 Suzhou Zelgen Biopharmaceuticals
- 54.83
- -0.83-1.49%
Suzhou Zelgen Biopharmaceuticals News
Announcement of the resolution of the 14th meeting of the second board of directors of Zejing Pharmaceutical.
Selection and Appointment System of Zejing Accounting Firm (Established in June 2024)
Announcement of the resolution of the 13th meeting of the second session of Zejing Pharmaceutical's supervisory board.
Announcement on the renewal of the company's auditing agency for the year 2024 by Zejing Pharmaceutical.
Announcement from Zejing Pharmaceutical regarding the use of temporarily idle raised funds for cash management.
Announcement on the Cancellation of Restricted Stock Incentive Plan for 2021 and the Unallocated Restricted Stocks of ZEJUN Pharma
China International Finance Co., Ltd.'s verification opinion on the use of part of the temporarily idle raised funds by Suzhou Zejing Biopharmaceutical Co., Ltd. for cash management matters.
Notice on the convening of the 2023 annual shareholders' meeting of Zejing Pharmaceuticals.
Legal Opinion from Junlan Law Firm Shanghai regarding the Cancellation of 2021 Restricted Stock Incentive Plan of Suzhou Zejing Biopharmaceutical Co., Ltd.
Zejing Pharmaceutical's Announcement on Voluntary Disclosure Submission of Application for Marketing of Injectable Recombinant Human Thyroid Stimulating Hormone Biological Products
Zejing Pharmaceutical Investor Relations Activity Record Form (May 21 to May 29, 2024)
Announcement of Zejing Pharmaceutical on Voluntary Disclosure of the Notice of Approval of Gicaxitinib Hydrochloride Tablets for Drug Clinical Trials
Zejing Pharmaceutical's announcement on voluntary disclosure of clinical data and latest developments of ZG005 and ZGGS18 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Announcement of Zejing Pharmaceutical on participating in the 2023 Pharmaceutical Special Group Performance Briefing
Zejing Pharmaceutical Investor Relations Activity Record List (April 22-April 26, 2024)
China International Finance Corporation Limited's Continued Supervision and Sponsorship Report on the Initial Public Offering and Listing of Suzhou Zejing Biopharmaceutical Co., Ltd.
China International Finance Corporation's 2023 Continuous Supervision Work Site Inspection Report on Suzhou Zejing Biopharmaceutical Co., Ltd.
Announcement of Resolutions of the 12th Meeting of the 2nd Supervisory Board of Zejing Pharmaceutical
Summary of Zejing Pharmaceutical's 2023 Annual Report
2023 Audit Report of Suzhou Zejing Biopharmaceutical Co., Ltd. issued by Xinyong Zhonghe Certified Public Accountants (Special General Partnership)
Analysis
Price Target
No Data
